Guideline for the Antibiotic Use in Acute Gastroenteritis

키워드

참고문헌 (110)

1. "Infectious diseases surveillance yearbook" (2017)[URL]
2. Dewey-Mattia D, "Surveillance for foodborne disease outbreaks-United States, 2009-2015", MMWR Surveill Summ, 67, pp.1~11 (2018)
3. Crump JA, "The global burden of typhoid fever", Bull World Health Organ, 82, pp.346~353 (2004)
4. 김석호, "Salmonella Serovars from Foodborne and Waterborne Diseases in Korea, 1998-2007: Total Isolates Decreasing Versus Rare Serovars Emerging", Journal of Korean Medical Science, 25(12), pp.1693~1699 (2010), 대한의학회
5. Yoo Sunmi, "Epidemiology of Salmonella enterica Serotype Typhi Infections in Korea for Recent 9 Years: Trends of Antimicrobial Resistance", Journal of Korean Medical Science, 19(1), pp.15~20 (2004), 대한의학회
6. 고성준, "An Outbreak of Gastroenteritis Caused by Norovirus-Contaminated Groundwater at a Waterpark in Korea", Journal of Korean Medical Science, 26(1), pp.28~32 (2011), 대한의학회
7. 대한감염학회, "소화기계 감염 진료지침 권고안", Infection and Chemotherapy, 42(6), pp.323~361 (2010), 대한감염학회
8. DuPont HL. Clinical practice, "Bacterial diarrhea", N Engl J Med, 361, pp.1560~1569 (2009)
9. "Infectious disease portal"[URL]
10. Wu CJ, "A new health threat in Europe : Shiga toxin-producing Escherichia coli O104 : H4infections", J Microbiol Immunol Infect, 44, pp.390~393 (2011)
11. Frank C, "Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4outbreak in Germany", N Engl J Med, 365, pp.1771~1780 (2011)
12. Rangel JM, "Epidemiology of Escherichia coli O157:H7outbreaks, United States, 1982-2002", Emerg Infect Dis, 11, pp.603~609 (2005)
13. Min Ji Kim, "Identification of Shiga Toxin-producing E. coli Isolated from Diarrhea Patients and Cattle in Gwangju Area, Korea", Journal of Bacteriology and Virology, 39(1), pp.29~39 (2009), 대한미생물학회
14. Mody RK, "Infections in pediatric postdiarrheal hemolytic uremic syndrome : factors associated with identifying shiga toxin-producing Escherichia coli", Arch Pediatr Adolesc Med, 166, pp.902~909 (2012)
15. Croxen MA, "Recent advances in understanding enteric pathogenic Escherichia coli", Clin Microbiol Rev, 26, pp.822~880 (2013)
16. Tarr PI, "Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome", Lancet, 365, pp.1073~1086 (2005)
17. "Traveler's health: travelers' diarrhea"[URL]
18. Slutsker L, "Escherichia coli O157 : H7 diarrhea in the United States : clinical and epidemiologic features", Ann Intern Med, 126, pp.505~513 (1997)
19. Mutsch M, "Post-infectious sequelae of travelers' diarrhea : irritable bowel syndrome", J Travel Med, 21, pp.141~143 (2014)
20. Connor BA, "Sequelae of traveler's diarrhea: focus on postinfectious irritable bowel syndrome", Clin Infect Dis, 41(Suppl 8), pp.S577~S586 (2005)
21. 고성준, "배양검사로 확진된 지역사회 세균성 장염 환자에서 과민성 장증후군의 발생률과 위험요인", 대한소화기학회지, 60(1), pp.13~18 (2012), 대한소화기학회[DOI]
22. McAuliffe GN, "Systematic application of multiplex PCR enhances the detection of bacteria, parasites, and viruses in stool samples", J Infect, 67, pp.122~129 (2013)
23. Amrud K, "A comparison of the Allplex™ bacterial and viral assays to conventional methods for detection of gastroenteritis agents", BMC Res Notes, 11, pp.514~ (2018)
24. Cybulski RJ Jr, "Clinical impact of a multiplex gastrointestinal polymerase chain reaction panel in patients with acute gastroenteritis", Clin Infect Dis, 67, pp.1688~1696 (2018)
25. Zhou Y, "Characteristics of diarrheagenic Escherichia coli among children under 5 years of age with acute diarrhea : a hospital based study", BMC Infect Dis, 18, pp.63~ (2018)
26. Thakur N, "Molecular characterization of diarrheagenic Escherichia coli pathotypes: association of virulent genes, serogroups, and antibiotic resistance among moderate-to-severe diarrhea patients", J Clin Lab Anal, 32, pp.e22388~ (2018)
27. 김시현, "감염 질환의 현장 검사: 현황과 전망", 대한내과학회지, 93(2), pp.181~187 (2018), 대한내과학회
28. Ramanan P, "Syndromic panel-based testing in clinical microbiology", Clin Microbiol Rev, 31, pp.pii:e00024~pii:e00117 (2018)
29. Shane AL, "Infectious Diseases Society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea", Clin Infect Dis, 65, pp.e45~e80 (2017)
30. Parry CM, "Typhoid fever", N Engl J Med, 347, pp.1770~1782 (2002)
31. Bhan MK, "Typhoid and paratyphoid fever", Lancet, 366, pp.749~762 (2005)
32. Crump JA, "Antimicrobial resistance among invasive nontyphoidal Salmonella enterica isolates in the United States: National Antimicrobial Resistance Monitoring System, 1996 to 2007", Antimicrob Agents Chemother, 55, pp.1148~1154 (2011)
33. Angulo FJ, "Bacterial enteric infections in persons infected with human immunodeficiency virus", Clin Infect Dis, 21(Suppl 1), pp.S84~S93 (1995)
34. Keddy KH, "Systemic shigellosis in South Africa", Clin Infect Dis, 54, pp.1448~1454 (2012)
35. Cover TL, "Yersinia enterocolitica", N Engl J Med, 321, pp.16~24 (1989)
36. Haq SM, "Chronic liver disease and consumption of raw oysters : a potentially lethal combination--a review of Vibrio vulnificus septicemia", Am J Gastroenterol, 100, pp.1195~1199 (2005)
37. Lee A, "Detection of bloodstream infections in adults: how many blood cultures are needed?", J Clin Microbiol, 45, pp.3546~3548 (2007)
38. Olopoenia LA, "Widal agglutination test-100 years later : still plagued by controversy", Postgrad Med J, 76, pp.80~84 (2000)
39. House D, "Serology of typhoid fever in an area of endemicity and its relevance to diagnosis", J Clin Microbiol, 39, pp.1002~1007 (2001)
40. Waddington CS, "The challenge of enteric fever", J Infect, 68(Suppl 1), pp.S38~S50 (2014)
41. Holtz LR, "Acute bloody diarrhea : a medical emergency for patients of all ages", Gastroenterology, 136, pp.1887~1898 (2009)
42. Lopes RJ, "Infectious thoracic aortitis : a literature review", Clin Cardiol, 32, pp.488~490 (2009)
43. Karachalios G, "Infectious endocarditis due to Yersinia enterocolitica", Chemotherapy, 48, pp.158~159 (2002)
44. Hagiya H, "Mycotic abdominal aortic aneurysm caused by Campylobacter fetus : a case report and literature review", Ann Vasc Surg, 28, pp.1933~ (2014)
45. Plastaras L, "Acute colitis : differential diagnosis using multidetector CT", Clin Radiol, 70, pp.262~269 (2015)
46. Horiki N, "CT evaluation of infectious colitis", Nihon Shokakibyo Gakkai Zasshi, 99, pp.925~934 (2002)
47. Macari M, "CT of bowel wall thickening : significance and pitfalls of interpretation", AJR Am J Roentgenol, 176, pp.1105~1116 (2001)
48. Thoeni RF, "CT imaging of colitis", Radiology, 240, pp.623~638 (2006)
49. Riddle MS, "ACG clinical guideline: diagnosis, treatment, and prevention of acute diarrheal infections in adults", Am J Gastroenterol, 111, pp.602~622 (2016)
50. DuPont HL, "Acute infectious diarrhea in immunocompetent adults", N Engl J Med, 370, pp.1532~1540 (2014)
51. Surawicz CM, "Rectal biopsy helps to distinguish acute self-limited colitis from idiopathic inflammatory bowel disease", Gastroenterology, 86, pp.104~113 (1984)
52. Waye JD, "Differentiation of inflammatory bowel conditions by endoscopy and biopsy", Endoscopy, 24, pp.551~554 (1992)
53. ASGE Standards of Practice Committee, "The role of endoscopy in the management of patients with diarrhea", Gastrointest Endosc, 71, pp.887~892 (2010)
54. Barbut F, "Comparative value of colonic biopsy and intraluminal fluid culture for diagnosis of bacterial acute colitis in immunocompetent patients", Clin Infect Dis, 29, pp.356~360 (1999)
55. Goka AK, "The relative merits of faecal and duodenal juice microscopy in the diagnosis of giardiasis", Trans R Soc Trop Med Hyg, 84, pp.66~67 (1990)
56. Wahnschaffe U, "Diagnostic value of endoscopy for the diagnosis of giardiasis and other intestinal diseases in patients with persistent diarrhea from tropical or subtropical areas", Scand J Gastroenterol, 42, pp.391~396 (2007)
57. Goka AK, "Diagnosis of Strongyloides and hookworm infections : comparison of faecal and duodenal fluid microscopy", Trans R Soc Trop Med Hyg, 84, pp.829~831 (1990)
58. De Bruyn G, "Antibiotic treatment for travellers' diarrhoea", Cochrane Database Syst Rev, pp.CD002242~ (2000)
59. Riddle MS, "Guidelines for the prevention and treatment of travelers'diarrhea: a graded expert panel report", J Travel Med, 24(suppl_1), pp.S57~S74 (2017)
60. Libman M, "Summary of the Committee to Advise on Tropical Medicine and Travel(CATMAT)statement on travellers' diarrhea", Can Commun Dis Rep, 41, pp.272~284 (2015)
61. DuPont HL, "Expert review of the evidence base for self-therapy of travelers' diarrhea", J Travel Med, 16, pp.161~171 (2009)
62. Annual epidemiological report 2014 : food-and waterborne diseases and zoonoses, "Bartels C", ECDC, ~ (2014)
63. Eurosurveillance editorial team, "European Union Summary Report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food 2012 published", Euro Surveill, 19, pp.20748~ (2014)
64. Zaidi MB, "Antimicrobial-resistant Campylobacter in the food chain in Mexico", Foodborne Pathog Dis, 9, pp.841~847 (2012)
65. Serichantalergs O, "PFGE, Lior serotype, and antimicrobial resistance patterns among Campylobacter jejuni isolated from travelers and US military personnel with acute diarrhea in Thailand, 1998-2003", Gut Pathog, 2, pp.15~ (2010)
66. 김난옥, "Enteric Bacteria Isolated from Diarrheal Patients in Korea in 2014", Osong Public Health and Research Perspectives, 6(4), pp.233~240 (2015), 질병관리청
67. 조인주, "국내 한 대학병원의 2001-2010년 장염 세균 분리 추세와 항균제 감수성 양상", Annals of Clinical Microbiology, 16(1), pp.45~51 (2013), 대한임상미생물학회
68. Infante RM, "Enteroaggregative Escherichia coli diarrhea in travelers : response to rifaximin therapy", Clin Gastroenterol Hepatol, 2, pp.135~138 (2004)
69. Riddle MS, "Trial Evaluating Ambulatory Therapy of Travelers' Diarrhea (TrEAT TD) study: a randomized controlled trial comparing 3 single-dose antibiotic regimens with loperamide", Clin Infect Dis, 65, pp.2008~2017 (2017)
70. DuPont HL, "Rifaximin versus ciprofloxacin for the treatment of traveler's diarrhea: a randomized, double-blind clinical trial", Clin Infect Dis, 33, pp.1807~1815 (2001)
71. Ochoa TJ, "Rifaximin does not induce toxin production or phage-mediated lysis of shiga toxin-producing Escherichia coli", Antimicrob Agents Chemother, 51, pp.2837~2841 (2007)
72. Ohara T, "Effects of azithromycin on shiga toxin production by Escherichia coli and subsequent host inflammatory response", Antimicrob Agents Chemother, 46, pp.3478~3483 (2002)
73. Zhang X, "Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice", J Infect Dis, 181, pp.664~670 (2000)
74. Safdar N, "Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157 : H7 enteritis : a meta-analysis", JAMA, 288, pp.996~1001 (2002)
75. Freedman SB, "Shiga toxin-producing Escherichia coli infection, antibiotics, and risk of developing hemolytic uremic syndrome: A meta-analysis", Clin Infect Dis, 62, pp.1251~1258 (2016)
76. Bennish ML, "Treatment of shigellosis: III. Comparison of one- or two-dose ciprofloxacin with standard 5-day therapy. A randomized, blinded trial", Ann Intern Med, 117, pp.727~734 (1992)
77. Ternhag A, "A meta-analysis on the effects of antibiotic treatment on duration of symptoms caused by infection with Campylobacter species", Clin Infect Dis, 44, pp.696~700 (2007)
78. Kuschner RA, "Use of azithromycin for the treatment of Campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalent", Clin Infect Dis, 21, pp.536~541 (1995)
79. Nelson JD, "Treatment of Salmonella gastroenteritis with ampicillin, amoxicillin, or placebo", Pediatrics, 65, pp.1125~1130 (1980)
80. Onwuezobe IA, "Antimicrobials for treating symptomatic non-typhoidal Salmonella infection", Cochrane Database Syst Rev, 11, pp.CD001167~ (2012)
81. Oh JY, "Changes in patterns of antimicrobial susceptibility and integron carriage among Shigella sonnei isolates from southwestern Korea during epidemic periods", J Clin Microbiol, 41, pp.421~423 (2003)
82. Spruill WJ, "Diarrhea, constipation, and irritable bowel syndrome", pp.617~623 (2007), McGraw Hill Medical
83. DuPont HL, "Symptomatic treatment of diarrhea with bismuth subsalicylate among students attending a Mexican university", Gastroenterology, 73, pp.715~718 (1977)
84. DuPont HL, "Bismuth subsalicylate in the treatment and prevention of diarrheal disease", Drug Intell Clin Pharm, 21, pp.687~693 (1987)
85. Primi MP, "Racecadotril demonstrates intestinal antisecretory activity in vivo", Aliment Pharmacol Ther, 13(Suppl 6), pp.3~7 (1999)
86. Salazar-Lindo E, "Racecadotril in the treatment of acute watery diarrhea in children", N Engl J Med, 343, pp.463~467 (2000)
87. Wang HH, "A blind, randomized comparison of racecadotril and loperamide for stopping acute diarrhea in adults", World J Gastroenterol, 11, pp.1540~1543 (2005)
88. Schiller LR, "Mechanism of the antidiarrheal effect of loperamide", Gastroenterology, 86, pp.1475~1480 (1984)
89. Stoll R, "Calmodulin-mediated effects of loperamide on chloride transport by brush border membrane vesicles from human ileum", Gastroenterology, 95, pp.69~76 (1986)
90. Li ST, "Loperamide therapy for acute diarrhea in children: systematic review and meta-analysis", PLoS Med, 4, pp.e98~ (2007)
91. Riddle MS, "Effect of adjunctive loperamide in combination with antibiotics on treatment outcomes in traveler's diarrhea : a systematic review and meta-analysis", Clin Infect Dis, 47, pp.1007~1014 (2008)
92. Johnson PC, "Comparison of loperamide with bismuth subsalicylate for the treatment of acute travelers' diarrhea", JAMA, 255, pp.757~760 (1986)
93. DuPont HL, "Adverse effect of lomotil therapy in shigellosis", JAMA, 226, pp.1525~1528 (1973)
94. Bos J, "Fatal necrotizing colitis following a foodborne outbreak of enterotoxigenic Clostridium perfringens type A infection", Clin Infect Dis, 40, pp.e78~e83 (2005)
95. Koo HL, "Antimotility agents for the treatment of Clostridium difficile diarrhea and colitis", Clin Infect Dis, 48, pp.598~605 (2009)
96. DuPont HL, "A randomized, open-label comparison of nonprescription loperamide and attapulgite in the symptomatic treatment of acute diarrhea", Am J Med, 88, pp.20S~23S (1990)
97. Portnoy BL, "Antidiarrheal agents in the treatment of acute diarrhea in children", JAMA, 236, pp.844~846 (1976)
98. Dinleyici EC, "Lactobacillus reuteri DSM 17938 effectively reduces the duration of acute diarrhoea in hospitalised children", Acta Paediatr, 103, pp.e300~e305 (2014)
99. Freedman SB, "Treatment of acute gastroenteritis in children : an overview of systematic reviews of interventions commonly used in developed countries", Evid Based Child Health, 8, pp.1123~1137 (2013)
100. Allen SJ, "Probiotics for treating acute infectious diarrhoea", Cochrane Database Syst Rev, pp.CD003048~ (2010)
101. Shane AL, "Guide to designing, conducting, publishing and communicating results of clinical studies involving probiotic applications in human participants", Gut Microbes, 1, pp.243~253 (2010)
102. Buydens P, "Efficacy of SF 68 in the treatment of acute diarrhea. A placebo-controlled trial", Scand J Gastroenterol, 31, pp.887~891 (1996)
103. Wunderlich PF, "Double-blind report on the efficacy of lactic acid-producing Enterococcus SF68 in the prevention of antibiotic-associated diarrhoea and in the treatment of acute diarrhoea", J Int Med Res, 17, pp.333~338 (1989)
104. Mitra AK, "A double-blind, controlled trial of bioflorin (Streptococcus faecium SF68) in adults with acute diarrhea due to Vibrio cholerae and enterotoxigenic Escherichia coli", Gastroenterology, 99, pp.1149~1152 (1990)
105. Kochan P, "Lactobacillus rhamnosus administration causes sepsis in a cardiosurgical patient--is the time right to revise probiotic safety guidelines?", Clin Microbiol Infect, 17, pp.1589~1592 (2011)
106. Rijkers GT, "Guidance for substantiating the evidence for beneficial effects of probiotics: current status and recommendations for future research", J Nutr, 140, pp.671S~676S (2010)
107. Ouwehand AC, "A review of dose-responses of probiotics in human studies", Benef Microbes, 8, pp.143~151 (2017)
108. Chapman CM, "Health benefits of probiotics: are mixtures more effective than single strains?", Eur J Nutr, 50, pp.1~17 (2011)
109. McFarland LV, "Meta-analysis of probiotics for the prevention of traveler's diarrhea", Travel Med Infect Dis, 5, pp.97~105 (2007)
110. Sazawal S, "Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials", Lancet Infect Dis, 6, pp.374~382 (2006)

관련 논문AI추천